Science Market Update

UC Davis Receives $2.5 Million Cancer Research Grant

Posted by BCI Staff on Fri, May 18, 2018

Last Fall, UC Davis' Comprehensive Cancer Center  received its first National Cancer Institute (NCI) Moonshot Grant of $2.5 million to research two types of cancers in dogs that are very similar to cancer in humans. 

UC Davis boasts both a world renowned veterinary school and medical school. Researchers are equipped with the tools to examine the link between cancer in dogs and cancer in humans. UC Davis has a Comparative Oncology Program at the Comprehensive Cancer Center, one of very few in the nation.

The program allows for veterinarians and physicians to work together to find creative cancer solutions. Robert Canter, a surgical oncologist at the Davis Comprehensive Cancer Center, and Robert Rehun, a veterinary oncologist, plan to conduct various research trials with the Moonshot Grant.

The trials will be focused on isolating dogs' natural killer cells. Killer cells are white blood cells that are particulary good at eliminating cells infected with viruses or cancer cells. Once the killer cells are isolated, researchers hope to connect the killer cells with human IL15. IL15 is a cytokine that might help activate the killer cells in human patients. 

This study is just one example of the many different projects that UC Davis facilitates to help advance cancer research. This past year, the Davis Comprehensive Cancer Center received $7.3 million in support. The Biomedical Technology Program at the Cancer Center alone has over 20 active projects and almost $24 million in funding.

 

Read More

Tags: CA, University of California Davis Medical Center, Southwest, UCDMC, BioResearch Product Faire Event, Sacramento, 2018, Oncology, Cancer Immunotherapy

Washington University, St. Louis: $6 Million in Leukemia Research Funding

Posted by Rebecca Inch-Partridge on Thu, Dec 07, 2017

According to the National Cancer Institute (NCI) there are over 380,000 people living with leukemia in the United States. Each year roughly 24,500 people die from the disease and over 62,000 new cases are diagnosed. To improve treatment options for leukemia patients, the NCI recently awarded John DiPersio, MD, PhD of Washington University, St. Louis $6 million in research funding. The Professor of Medicine in Oncology at the university’s School of Medicine will use the seven years of funding to support three major areas of leukemia research in his lab. These include: improving the effectiveness of standard chemotherapy, preventing graft-versus-host disease, and developing new immunotherapies.

Read More

Tags: Washington University St. Louis, Washington University, WashU, WUSTL, Leukemia, cancer research, Cancer, Research Funding, biotech vendor show, cancer research funding, Bioresearch Grant, Biotechnology trade show, NIH awards 2017, Cancer Therapeutics, Cancer Immunotherapy

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News